Kaempferol and atherosclerosis: From mechanism to medicine

Crit Rev Food Sci Nutr. 2024;64(8):2157-2175. doi: 10.1080/10408398.2022.2121261. Epub 2022 Sep 13.

Abstract

Natural products possess pleiotropic cardiovascular protective effects owing to their anti-oxidation, anti-inflammation and anti-thrombotic properties. Kaempferol, (3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one), is a kind of naturally occurring flavonoid existing in many common fruits and vegetables (e.g., onions, broccoli, strawberries and grapes) and particularly in traditional Chinese medicine as exemplified by Ginkgo biloba. Epidemiological, preclinical and clinical studies have revealed an inverse association between the consumption of kaempferol-containing foods and medicines and the risk of developing cardiovascular diseases. Numerous translational studies in experimental animal models and cultured cells have demonstrated a wide range of pharmacological activities of kaempferol. In this article, we reviewed the antioxidant, anti-inflammatory and cardio-protective activities of kaempferol and elucidated the potential molecular basis of the therapeutic capacity of kaempferol by focusing on its anti-atherosclerotic effects. Overall, the review presents the health benefits of kaempferol-containing plants and medicines and reflects on the potential of kaempferol as a possible drug candidate to prevent and treat atherosclerosis, the underlying pathology of most cardiovascular diseases.

Keywords: Kaempferol; anti-inflammatory effects; antioxidant; cardiovascular diseases; medicinal plants.

Publication types

  • Review

MeSH terms

  • Animals
  • Antioxidants
  • Atherosclerosis* / drug therapy
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / prevention & control
  • Flavonoids
  • Kaempferols / pharmacology
  • Kaempferols / therapeutic use

Substances

  • Kaempferols
  • Flavonoids
  • Antioxidants